HSP90AA1 and glioblastoma: Inhibitors of Hsp90, such as Hsp90, and PI3K, such as BKM120, both with and without RT, are effective against GBM cells and tumors Wachsberger et al. suggesting that their efficacy is independent of PTEN/p53 status [76].